From major journals, first or last author from the Institute for Cancer Research
Foldvari Z, Brennan MS, Titov A, Jacobsen SEW, Olweus J(2025) Targeting the roots of myeloid malignancies with T cell receptors Nat Rev Cancer(in press) DOI 10.1038/s41568-025-00857-0, PubMed 40841587
Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, Masilamani T, Theriault G, St-Onge R, D'costa L, Lingjaerde OC, Haugen MH, Engebraaten O(2025) High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy Breast Cancer Res, 27(1), 143 DOI 10.1186/s13058-025-02092-9, PubMed 40790765
Brodal HP, Pharo H, Vedeld HM, Lind GE(2025) PoDCall: a robust tool for automated droplet classification in DNA-methylation droplet digital PCR Mol Oncol(in press) DOI 10.1002/1878-0261.70105, PubMed 40761129
Sagini K, Selvarajah M, Romero S, Bassols-Citores E, Martin-Gracia B, Ramirez-Garrastacho M, Rise F, Endzeliņš E, Sadovska L, Skorinkina D, Boguševiča M, Cešeiko R, Čampa M, Klavina A, Linē A, Llorente A(2025) The Redox Enzyme Thioredoxin Is Increased in Plasma Extracellular Vesicles From Endurance-Trained Females in Response to Acute Exercise FASEB J, 39(16), e70927 DOI 10.1096/fj.202500678R, PubMed 40810354
Foldvari Z, Brennan MS, Titov A, Jacobsen SEW, Olweus J(2025) Targeting the roots of myeloid malignancies with T cell receptors Nat Rev Cancer(in press) DOI 10.1038/s41568-025-00857-0, PubMed 40841587
Nassar AH, Kim C, Adeyelu T, Bou Farhat E, Abushukair H, Rakaee M, Matteson K, Lau SF, Takabe Y, Ocejo A, Ardeshir-Larijani F, Leal T, Ramalingam S, Alam S, Gray JE, Hicks J, Kaldas D, Baena J, Berjaga MZ, Nana FA, Grohe C, Leuders H, Citarella F, Cortellini A, Mingo ECet al.(2025) Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma Nat Commun, 16(1), 7717 DOI 10.1038/s41467-025-63091-0, PubMed 40830141